oligonucleotides target TGF-alpha (Genta)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameoligonucleotides target TGF-alpha (Genta)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionTransforming growth factor alpha modulators
TargetsTransforming growth factor alpha
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenta Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenta Incorporated
Active IndicationsN/A
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A